Suppr超能文献

在鼠伤寒沙门氏菌致突变性试验中,人源肝细胞和肝脏9000 X g 上清液对诱变剂的激活作用。与大鼠肝脏制剂的比较。

Activation of mutagens by hepatocytes and liver 9000 X g supernatant from human origin in the Salmonella typhimurium mutagenicity assay. Comparison with rat liver preparations.

作者信息

Neis J M, Yap S H, van Gemert P J, Roelofs H M, Bos R P, Henderson P T

出版信息

Mutat Res. 1986 Feb;164(1):41-51. doi: 10.1016/0165-1161(86)90040-3.

Abstract

The mutagenicity of 10 known genotoxic compounds, of several chemical classes, was measured in Salmonella typhimurium mutagenicity assays comprising isolated human hepatocytes or human liver 9000 X g supernatant (S9) from 4 different individuals, as activating system. The mutagenic activity of several compounds as determined with the Salmonella/hepatocyte suspension assay showed obvious differences when compared with the values obtained in the Salmonella/S9 plate assay. For instance, the mutagenic activity of BZ, DMN and DEN appeared to be much higher in the hepatocyte assay than in the S9 assay. However, 2-AF and 2-AAF were activated more effectively into mutagens in the S9 assay than in the hepatocyte assay. 2-AF was slightly more mutagenic than 2-AAF in the hepatocyte assay, whereas it was far more mutagenic than 2-AAF in the S9 assay. DMN was found more mutagenic than DEN in the hepatocyte assay, whereas in the S9 assay DEN appeared to be slightly more mutagenic. Furthermore, great interindividual differences in the metabolic activation of certain compounds, e.g. BZ and DMN, were observed in the hepatocyte suspension assay, whereas these variations were less evident in the S9 plate assay. Comparison of the mutagenicity data obtained with the human liver preparations, with those obtained with rat liver preparations, showed great interspecies differences in the capacity to activate certain chemicals into mutagens. The use of human liver preparations, in particular isolated human hepatocytes, may be of great value in studies on inter- and intraspecies variations in metabolic activation of genotoxic agents.

摘要

在鼠伤寒沙门氏菌致突变性试验中,以分离的人肝细胞或来自4个不同个体的人肝9000×g上清液(S9)作为活化系统,测定了10种已知的具有基因毒性的化合物(分属几种化学类别)的致突变性。与沙门氏菌/S9平板试验所得值相比,用沙门氏菌/肝细胞悬液试验测定的几种化合物的致突变活性显示出明显差异。例如,在肝细胞试验中,BZ、DMN和DEN的致突变活性似乎比在S9试验中高得多。然而,在S9试验中,2 - AF和2 - AAF比在肝细胞试验中更有效地被激活为诱变剂。在肝细胞试验中,2 - AF的致突变性略高于2 - AAF,而在S9试验中,其致突变性远高于2 - AAF。在肝细胞试验中发现DMN比DEN的致突变性更强,而在S9试验中,DEN的致突变性似乎略高。此外,在肝细胞悬液试验中观察到某些化合物(如BZ和DMN)的代谢活化存在很大的个体差异,而这些差异在S9平板试验中不太明显。将用人肝制剂获得的致突变性数据与用大鼠肝制剂获得的数据进行比较,结果表明在将某些化学物质激活为诱变剂的能力方面存在很大的种间差异。使用人肝制剂,特别是分离的人肝细胞,在研究基因毒性剂代谢活化的种间和种内变异方面可能具有很大价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验